Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Year: 2012
Type: review
Source: Clinical Pharmacokinetics
Institutions: Novartis (United States), Novartis (Switzerland)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: canakinumab, IL-1β, monoclonal antibodies, pharmacokinetics, pharmacodynamics, cryopyrin-associated periodic syndromes, rheumatoid arthritis, psoriasis, asthma, binding affinity, population pharmacokinetic model, subcutaneous bioavailability, elimination half-life, anti-inflammatory therapy
Open Access status: bronze
OpenAlex ID: W2151012287
